关键词: Acupuncture Acute Meta-analysis Non-specific low back pain Subacute Systematic review

Mesh : Humans Low Back Pain / drug therapy therapy Acupuncture Therapy / methods Administration, Oral Acute Pain / drug therapy therapy Treatment Outcome Analgesics / therapeutic use administration & dosage

来  源:   DOI:10.1007/s11916-023-01201-7   PDF(Pubmed)

Abstract:
OBJECTIVE: Pharmacologic intervention do not always achieve benefits in the treatment of acute/subacute non-specific low back pain (NSLBP). We assessed efficacy and safety of acupuncture for acute/subacute NSLBP as alternative treatment.
RESULTS: We searched PubMed, Web of Science, Embase, Cochrane Library, Scopus, Epistemonikos, CNKI, Wan Fang Database, VIP database, CBMLD, CSTJ, clinical trials, EUCTR, World WHO ICTRP, and ChiCTR for randomized controlled trials, cross-over studies, and cohort studies of NSLBP treated by acupuncture versus oral medication from inception to 23th April 2022. A total of 6 784 records were identified, and 14 studies were included 1 263 participants in this review. The results of the meta-analysis indicated that acupuncture therapy was slightly more effective than oral medication in improving pain (P < 0.00001, I2 = 92%, MD = -1.17, 95% CI [-1.61, -0.72]). According to the results of the meta-analysis, acupuncture therapy exhibited a significant advantage over oral medication with a substantial effect (P < 0.00001, I2 = 90%, SMD = -1.42, 95% CI [-2.22, -0.62]). Based on the results of the meta-analysis, acupuncture therapy was associated with a 12% improvement rate compared to oral medication in patients with acute/subacute NSLBP (P < 0.0001, I2 = 54%, RR = 1.11, 95% CI [1.05, 1.18]). Acupuncture is more effective and safer than oral medication in treating acute/subacute NSLBP. This systematic review is poised to offer valuable guidance to clinicians treating acute/subacute NSLBP and potentially benefit the afflicted patients.
BACKGROUND: This review was registered in PROSPERO ( http://www.crd.york.ac.uk/prospero ) with registration number CRD42021278346.
摘要:
目的:药物干预在急性/亚急性非特异性下腰痛(NSLBP)的治疗中并不总是能获益。我们评估了针刺作为急性/亚急性NSLBP替代治疗的疗效和安全性。
结果:我们搜索了PubMed,WebofScience,Embase,科克伦图书馆,Scopus,认识论,CNKI,万方数据库,VIP数据库,CBMLD,CSTJ,临床试验,EUCTR,世界世卫组织ICTRP,和ChiCTR用于随机对照试验,交叉研究,从开始到2022年4月23日,针灸与口服药物治疗NSLBP的队列研究。共识别出6.784条记录,14项研究包括1.263名参与者.荟萃分析的结果表明,针灸疗法在改善疼痛方面比口服药物略有效(P<0.00001,I2=92%,MD=-1.17,95%CI[-1.61,-0.72])。根据荟萃分析的结果,与口服药物相比,针灸疗法具有显著的优势,具有显著的效果(P<0.00001,I2=90%,SMD=-1.42,95%CI[-2.22,-0.62])。根据荟萃分析的结果,在急性/亚急性NSLBP患者中,针灸疗法与口服药物相比有12%的改善率(P<0.0001,I2=54%,RR=1.11,95%CI[1.05,1.18])。针灸治疗急性/亚急性NSLBP比口服药物更有效,更安全。这项系统评价旨在为临床医生治疗急性/亚急性NSLBP提供有价值的指导,并可能使患病患者受益。
背景:此评论已在PROSPERO(http://www。crd.约克。AC.英国/普适诺),注册号为CRD42021278346。
公众号